Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q3 2017 · 10-Q
Revenue$5.59M$5.59M+90.2% vs Q3 2016 Net Income-$589.98K-$589.98KN/M vs Q3 2016 EPS Diluted-$0.01-$0.01N/M vs Q3 2016 Gross Profit$3,997,649+111.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flowderived$442,937N/M Free Cash Flowderived$442,937N/M Margins · derivedGross margin71.5%+7.2 pt vs Q3 2016
Operating margin-8.6%+45.1 pt vs Q3 2016
Net margin-10.6%+54.1 pt vs Q3 2016
ended Sep 30, 2017 · filed Nov 8, 2017 · 39 d after period end